MICAELA ANTZOULATOS: Open Payments
NPI 1538715578 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 31 payments from 10 companies in 2025. Trend: 2023 $201 · 2024 $217 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 5 | $194 |
| Regeneron Healthcare Solutions, Inc. | 4 | $127 |
| GlaxoSmithKline, LLC. | 5 | $88 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $78 |
| GENZYME CORPORATION | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 4 | $56 |
| AERIN MEDICAL INC. | 2 | $45 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $42 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: Xhance, DUPIXENT, NUCALA, NEFFY, VOQUEZNA, VIVAER STYLUS, JOURNAVX, LIBTAYO.
Industry payments across NC — which companies pay providers there.
